Tag: Covaxin News

Bharat Biotech firmly condemns baseless reports on COVAXIN Development

Bharat Biotech today strongly condemned fallacious and misleading information report recently by a foreign media. The company in

India Approves COVAXIN for Children 6 to 12 Years Age

Hyderabad: India has approved COVAXIN for children 6 to 12 years of age today. Bharat Biotech, a global

Science is Rewarding, if You Defeat the Odds – COVAXIN Scientist Krishna

Science pays, if you are passionate, and committed towards it, COVAXIN Scientist Krishna Ella said. Addressing young entrepreneurs

India’s COVAXIN, Long Awaited in the US to be Evaluated by FDA

COVAXIN maker Bharat Biotech announced today that U.S. Food and Drug Administration (FDA) has lifted its clinical hold

COVID Vaccine for 15-18 Years: Over 50% Children Gets COVAXIN

COVID Vaccine for 15-18 Years has got tremendous momentum in India since its launch. India's Health Minister Mansukh

COVID Vaccine Precautionary Dose: India Crosses 50 Lakh Milestone

COVID Vaccine Precautionary Dose campaign which began on January 10, crossed a figure of 50 lakh jabs, as the

COVAXIN Booster Neutralizes, COVID-19 Omicron and Delta Variants – New Study

COVAXIN Booster Shown to Neutralize Both Omicron and Delta Variants of SARS-CoV-2. Bharat Biotech announced today the results

COVAXIN booster boosts antibody levels by 19-97 fold against variants – Latest Results

COVAXIN booster increases 19-97 fold rise in antibody levels against Covid-19 variants of concern. Results from the highly

India Begins COVAXIN For Children, Bharat Biotech in Full Preparedness to Serve the Demand

India has kicked off a massive campaign to begin COVAXIN for Children today. As the vaccination for children

COVAXIN Open Vial: Do Not Worry About its Wastage

Bharat Biotech, India's indigenous vaccine maker noted that health care workers do not have to worry about COVAXIN

COVAXIN Protects You From Multi- Covid-19 Variants – New NII study

COVAXIN, India's Indigenous vaccine developed by Bharat Biotech unlike existing vaccines against , it has been found that

CDSCO Extends India’s COVAXIN Shelf Life to 12 Months Now

The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Covid-19 vaccine Covaxin Shelf Life to